Render Target: SSR
Render Timestamp: 2024-10-24T19:30:27.263Z
Commit: 56767fe525c928647c8401233a175d0d607d385d
XML generation date: 2024-09-20 06:20:22.528
Product last modified at: 2024-07-01T15:45:08.601Z
View Featured Offers >>
1% for the planet logo
PDP - Template Name: Antibody Sampler Kit
PDP - Template ID: *******4a3ef3a
  1. Products /
  2. Primary Antibodies /
  3. BAF Complex Antibody Sampler Kit II

BAF Complex Antibody Sampler Kit II #58214

    Product Information

    Kit Usage Information

    Protocols

    Product Description

    The BAF Complex Antibody Sampler Kit II provides an economical means of detecting levels of various BAF complex components. The kit contains enough primary antibodies to perform at least two western blot experiments.

    Specificity / Sensitivity

    Each antibody in the BAF Complex Antibody Sampler Kit II recognizes endogenous levels of its specific target.

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly1293 of human ARID1A/BAF250A protein, Ala1320 of human ARID1B/BAF250B protein, residues near the amino terminus of human Brg1 protein, resides surrounding Gly264 of human BRM protein, Gly975 of human SMARCC1/BAF155 protein, Ile818 of human SMARCC2/BAF170, and Leu34 of human SMARCE1/BAF57 protein.

    Background

    ATP-dependent chromatin remodeling complexes play an essential role in the regulation of various nuclear processes, such as gene expression, DNA replication, and repair (1,2). The SWI/SNF chromatin remodeling complex consists of more than 10 subunits with a single molecule of the ATPase catalytic subunit BRM or BRG1, but not both. The activities of these two subunits drive the disruption of histone-DNA contacts that lead to changes in accessibility of crucial regulatory elements within chromatin (2-5). The BRM/BRG1 containing SWI/SNF complexes are recruited to target promoters by transcription factors, such as nuclear receptors, p53, RB, and BRCA1 to regulate gene activation, cell growth, the cell cycle, and differentiation processes (1,6-9). BRM and BRG1 are also considered to be tumor suppressors and their expression levels are severely reduced in several cancer cell lines (10-13). SMARCC1/BAF155, SMARCC2/BAF170, and SMARCB1/BAF47 are members of the core subunits of the SWI/SNF complex, which is necessary for efficient nucleosome remodeling by BRG1 in vitro (14). ARID1A/BAF250A and ARID1B/BAF250B are DNA-binding members of the complex. They are highly homologous and mutually exclusive, with ARID1B/BAF250B being a critical vulnerability in ARID1A/BAF250A mutant cancers (15-17). SMARCC1, SMARCB1, and ARID1A are an essential part of the mouse embryonic stem cell specific SWI/SNF complex (esBAF). SMARCC1 is necessary for early embryogenesis, especially proper brain and visceral endoderm development (18-20). SMARCB1 is necessary for early embryogenesis and hepatocyte differentiation (21,22). ARID1A is critical for embryonic stem (ES) cell pluripotency and differentiation into mesoderm-derived cardiomyocytes and adipocytes (15). While SMARCC2 has been shown to be part of the SWI/SNF complex in non-pluripotent cells, it is absent in pluripotent ES cells. Expression of SMARCC2 has been shown to be up-regulated in neurons/neuronal progenitors upon differentiation of mouse ES cells with retinoic acid, and exogenous expression of SMARCC2 leads to loss of stem cell pluripotency and self renewal (23).
    1. Ho, L. and Crabtree, G.R. (2010) Nature 463, 474-84.
    2. Becker, P.B. and Hörz, W. (2002) Annu Rev Biochem 71, 247-73.
    3. Eberharter, A. and Becker, P.B. (2004) J Cell Sci 117, 3707-11.
    4. Bowman, G.D. (2010) Curr Opin Struct Biol 20, 73-81.
    5. Gangaraju, V.K. and Bartholomew, B. (2007) Mutat Res 618, 3-17.
    6. Lessard, J.A. and Crabtree, G.R. (2010) Annu Rev Cell Dev Biol 26, 503-32.
    7. Morettini, S. et al. (2008) Front Biosci 13, 5522-32.
    8. Wolf, I.M. et al. (2008) J Cell Biochem 104, 1580-6.
    9. Simone, C. (2006) J Cell Physiol 207, 309-14.
    10. Yamamichi, N. et al. (2005) Oncogene 24, 5471-81.
    11. Reisman, D.N. et al. (2002) Oncogene 21, 1196-207.
    12. Shen, H. et al. (2008) Cancer Res 68, 10154-62.
    13. Weissman, B. and Knudsen, K.E. (2009) Cancer Res 69, 8223-30.
    14. Phelan, M.L. et al. (1999) Mol Cell 3, 247-53.
    15. Wang, X. et al. (2004) Biochem J 383, 319-25.
    16. Helming, K.C. et al. (2014) Nat Med 20, 251-4.
    17. Gao, X. et al. (2008) Proc Natl Acad Sci U S A 105, 6656-61.
    18. Han, D. et al. (2008) Dev Biol 315, 136-46.
    19. Kim, J.K. et al. (2001) Mol Cell Biol 21, 7787-95.
    20. Schaniel, C. et al. (2009) Stem Cells 27, 2979-91.
    21. Klochendler-Yeivin, A. et al. (2000) EMBO Rep 1, 500-6.
    22. Gresh, L. et al. (2005) EMBO J 24, 3313-24.
    23. Ho, L. et al. (2009) Proc Natl Acad Sci U S A 106, 5181-6.

    Database Links

    UniProt ID: Q92922 , P51531 , Q969G3 , Q8TAQ2 , Q8NFD5 , O14497 , P51532


    Entrez-Gene Id: 6599 , 6595 , 6605 , 6601 , 57492 , 8289 , 6597


    限制使用

    除非 CST 的合法授书代表以书面形式书行明确同意，否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件，除非书 CST 的合法授书代表以书面形式书独接受， 否书均被拒书，并且无效。

    专品专有“专供研究使用”的专专或专似的专专声明， 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的， 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专，且专用于研专用途。将专品用于专断、专防或治专目的， 或专专售（专独或作专专成）或其他商专目的而专专专品，均需要 CST 的专独专可。客专：(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品，或使用专品制造任何商专专品，(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专，或使用专品开专任何与 CST 的专品或服专专争的专品或服专， (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专，(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品， (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专

    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.